<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the second most leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> related <z:hpo ids='HP_0011420'>deaths</z:hpo> in the western countries </plain></SENT>
<SENT sid="1" pm="."><plain>One of the forms of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is hereditary non-<z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (HNPCC), also known as "<z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e>" </plain></SENT>
<SENT sid="2" pm="."><plain>It is the most common hereditary form of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> accounting for 5%-10% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>HNPCC is a dominant autosomal <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> caused by germ line mutations in mismatch repair genes </plain></SENT>
<SENT sid="4" pm="."><plain>Human mismatch repair genes play a crucial role in genetic stability of DNA, the inactivation of which results in an increased rate of mutation and often a loss of mismatch repair function </plain></SENT>
<SENT sid="5" pm="."><plain>Recent studies have shown that certain mismatch repair genes are involved in the regulation of key cellular processes including <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, differential expression of mismatch repair genes particularly the contributions of MLH1 and MSH2 play important roles in therapeutic resistance to certain cytotoxic drugs such as <z:chebi fb="2" ids="27899">cisplatin</z:chebi> that is used normally as chemoprevention </plain></SENT>
<SENT sid="7" pm="."><plain>An understanding of the role of mismatch repair genes in molecular signaling mechanism of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and its involvement in HNPCC needs attention for further work into this important area of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> research, and this review article is intended to accomplish that goal of linkage of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> with HNPCC </plain></SENT>
<SENT sid="8" pm="."><plain>The current review was not intended to provide a comprehensive enumeration of the entire body of literature in the area of HNPCC or mismatch repair system or <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; it is rather intended to focus primarily on the current state of knowledge of the role of mismatch repair proteins in molecular signaling mechanism of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> as it relates to understanding of HNPCC </plain></SENT>
</text></document>